Gary Schaer to Dopamine Agonists
This is a "connection" page, showing publications Gary Schaer has written about Dopamine Agonists.
Connection Strength
0.056
-
Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA. 2003 Nov 05; 290(17):2284-91.
Score: 0.056
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.